A drug used to treat diabetes may also reduce the risk of heart attack and stroke in people who are not diabetic.

Researchers at the Cleveland Clinic found that semaglutide was able to reduce the risk by 20%, specifically in adults who are 45 and older who are considered overweight or obese.

“This marks the first intervention, either a lifestyle or a pharmacologic intervention, that’s ever been shown to reduce the risk of cardiovascular events in patients who are overweight and obese, but don’t have diabetes,” said Dr. Michael Lincoff, a cardiologist.

While semaglutide is currently available, it still needs to be reviewed by the FDA for an expansion of use.